tiprankstipranks
Trending News
More News >
Advertisement

AVSD - AI Analysis

Compare

Top Page

AVSD

Avantis Responsible International Equity ETF (AVSD)

Rating:65Neutral
Price Target:
$78.61
The Avantis Responsible International Equity ETF (AVSD) demonstrates solid performance driven by strong holdings like Novartis and ASML. Novartis contributes positively with its robust profitability, strategic investments, and shareholder-friendly initiatives, while ASML adds value through its growth prospects in EUV technology and strong financial performance. However, weaker holdings like SoftBank Group, with financial risks from high leverage and cash flow challenges, slightly weigh on the fund’s overall rating. Investors should note potential risks from sector concentration in financial and technology stocks.
Positive Factors
Strong Top Holdings
Several of the largest positions, such as SoftBank Group and Celestica, have delivered strong year-to-date gains, boosting the fund’s overall performance.
Global Diversification
The ETF has exposure to a wide range of countries, including Japan, the UK, and Australia, reducing reliance on any single market.
Low Expense Ratio
The fund charges a competitive expense ratio, making it cost-effective compared to many other international equity ETFs.
Negative Factors
High Financial Sector Exposure
The ETF has significant exposure to the financial sector, which could make it vulnerable to sector-specific downturns.
Underperforming Holdings
Some top holdings, like Royal Bank of Canada and Vinci SA, have shown weaker year-to-date performance, potentially dragging on returns.
Limited Emerging Market Exposure
The fund focuses heavily on developed markets, offering minimal exposure to faster-growing emerging economies.

AVSD vs. SPDR S&P 500 ETF (SPY)

AVSD Summary

The Avantis Responsible International Equity ETF (AVSD) is an investment fund that focuses on companies worldwide, emphasizing responsible and sustainable practices. It includes a mix of industries like financials, technology, and healthcare, with top holdings such as HSBC and Novartis. This ETF is ideal for investors looking to diversify globally while supporting ethical and sustainable businesses. However, since it invests in international markets, its performance can be affected by global economic conditions and currency fluctuations.
How much will it cost me?The Avantis Responsible International Equity ETF (AVSD) has an expense ratio of 0.23%, meaning you’ll pay $2.30 per year for every $1,000 invested. This is lower than the average for actively managed ETFs, as AVSD uses a systematic approach to investing rather than frequent trading, which helps keep costs down.
What would affect this ETF?The AVSD ETF, with its focus on developed markets outside the U.S. and strong exposure to sectors like financials and industrials, could benefit from global economic growth and increased demand for sustainable investments. However, it may face challenges from rising interest rates, which could impact financial stocks, and geopolitical tensions or regulatory changes in international markets. Its emphasis on responsible investing aligns with growing investor interest in sustainability, but sector-specific risks, such as technology volatility, could also affect performance.

AVSD Top 10 Holdings

The Avantis Responsible International Equity ETF (AVSD) leans heavily into developed markets outside the U.S., with a notable focus on financials and industrials. SoftBank Group has been a standout performer, riding strong momentum and driving gains for the fund, while Celestica’s impressive revenue growth adds further fuel. On the flip side, HSBC has been lagging, weighed down by challenges in the Hong Kong real estate market. The fund’s positioning in global heavyweights like Novartis and ASML provides steady support, but its sector concentration in financials means broader market trends could significantly sway performance.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
HSBC Holdings0.88%$3.35M$230.69B48.77%
78
Outperform
Novartis0.83%$3.15M$249.53B16.84%
78
Outperform
SoftBank Group0.81%$3.07M$229.24B186.30%
63
Neutral
ASML Holding0.76%$2.89M$398.35B47.17%
81
Outperform
Roche Holding AG0.76%$2.89MCHF217.35B4.21%
73
Outperform
Royal Bank Of Canada0.70%$2.66M$207.80B19.15%
75
Outperform
SAFRAN SA0.67%$2.56M€126.90B43.71%
67
Neutral
Vinci SA0.67%$2.55M€67.77B16.94%
75
Outperform
Celestica0.65%$2.49M$34.17B366.62%
76
Outperform
Sony Group0.65%$2.49M$175.52B61.69%
78
Outperform

AVSD Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
71.15
Positive
100DMA
69.26
Positive
200DMA
64.56
Positive
Market Momentum
MACD
0.41
Negative
RSI
61.66
Neutral
STOCH
95.99
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For AVSD, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 71.99, equal to the 50-day MA of 71.15, and equal to the 200-day MA of 64.56, indicating a bullish trend. The MACD of 0.41 indicates Negative momentum. The RSI at 61.66 is Neutral, neither overbought nor oversold. The STOCH value of 95.99 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AVSD.

AVSD Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$381.78M0.23%
65
Neutral
$950.07M0.50%
65
Neutral
$856.69M0.24%
63
Neutral
$752.72M0.50%
64
Neutral
$455.47M0.59%
61
Neutral
$271.03M0.49%
69
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AVSD
Avantis Responsible International Equity ETF
72.87
16.35
28.93%
TOUS
T. Rowe Price International Equity ETF
DFSI
Dimensional International Sustainability Core 1 ETF
SEIE
SEI Select International Equity ETF
FYLD
Cambria Foreign Shareholder Yield ETF
PPIE
Putnam PanAgora ESG International Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement